CNS vs CPF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CNS

34.6
AI Score
VS
CPF Wins

CPF

44.8
AI Score

Investment Advisor Scores

CNS

35score
Recommendation
SELL

CPF

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS CPF Winner
Revenue 94.41M 38.55M CNS
Net Income 29.96M 64.32M CPF
Net Margin 31.7% 166.9% CPF
ROE 9.9% 11.1% CPF
ROA 6.7% 0.9% CNS
Total Assets 450.12M 7.45B CPF
Free Cash Flow 4.31M 86.32M CPF

Relative Price Performance (Last 90 Days)

CNS 1M: +5.6% · 3M: -15.1% CPF 1M: +9.5% · 3M: +0.1%

Current Technical Phase

CNS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50

RSI (14): 49.8 · Price: $72.72

CPF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.3 · Price: $38.99

Fundamentals Snapshot

Metric CNS CPF
Market Cap — —
Forward P/E 19.6 10.6
Trailing P/E 22.7 11.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.4%
EPS 3.25 3.31
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CPF is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.